ロード中...
Neoadjuvant and adjuvant therapy for gastrointestinal stromal tumors
Gastrointestinal stromal tumors (GIST) are rare and mesenchymal in origin with a yearly incidence of 10‐15 cases per million people. If it is technically resectable, surgical resection is the mainstay of therapy regardless of tumor location,. Although complete (R0) resection can be achieved in up to...
保存先:
| 出版年: | Ann Gastroenterol Surg |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6345649/ https://ncbi.nlm.nih.gov/pubmed/30697609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ags3.12211 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|